Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.

Authors :: Autio KA
Farooki A
Glezerman IG
Chan A
Schneider CW
Barr HC
Seyboth BM
Kampel LJ
Danila DC
Rathkopf DE
Slovin SF
Scher HI
Morris MJ
Source :: Clinical genitourinary cancer [Clin Genitourin Cancer] 2015 Aug; Vol. 13 (4), pp. e305-e309. Date of Electronic Publication: 2014 Nov 22.
Publication Year :: 2015

Subjects :: Administration, Intravenous
Aged
Aged, 80 and over
Bone Density Conservation Agents administration & dosage
Bone Neoplasms secondary
Denosumab administration & dosage
Hospitalization statistics & numerical data
Humans
Hypocalcemia chemically induced
Male
Middle Aged
Prostatic Neoplasms, Castration-Resistant pathology
Risk Factors
Bone Density Conservation Agents adverse effects
Bone Neoplasms drug therapy
Calcium administration & dosage
Denosumab adverse effects
Hypocalcemia drug therapy
Prostatic Neoplasms, Castration-Resistant drug therapy

Full Text Access

Tools